Journal
NATURAL PRODUCT RESEARCH
Volume 31, Issue 10, Pages 1131-1141Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14786419.2016.1230113
Keywords
Kappaphycus alvarezii; oxocine carboxylate cyclic ether; antioxidative; anti-inflammatory; structure-activity relationship
Categories
Funding
- Science and Engineering Research Board (SERB) of Department of Science and Technology, Ministry of Science and Technology, New Delhi, India [SR/S1/OC-96/2012 SERB]
Ask authors/readers for more resources
An unprecedented non-isoprenoid oxocine carboxylate cyclic ether characterised as (3S, 4R, 5S, 6Z)-3-((R)-hexan-2-yl)-3,4,5,8-tetrahydro-4-methyl-2H-oxocin-5-yl acetate was isolated from the ethyl acetate-methanol extract of the red seaweed Kappaphycus alvarezii. The structure, as well as its relative stereochemistry, was proposed on the basis of extensive spectral data. The antioxidative activity of the isolated metabolite was found to have significantly greater as determined by 1, 1-diphenyl-2-picrylhydrazyl and 2,2-azino-bis-3-ethylbenzothiozoline-6-sulfonic acid radical scavenging activities (IC50 similar to 0.3mg/mL) compared to -tocopherol (IC50>0.6mg/mL) and was comparable to the synthetic antioxidants butylated hydroxytoluene and butylated hydroxyanisole (IC50 similar to 0.35-0.34mg/mL). The compound exhibited greater activity against COX-2 (cyclooxygenase-2) than COX-1 (cyclooxygenase-1) isoform, and therefore, the selectivity index remained significantly lesser (anti-COX-1(IC50): anti-COX-2(IC50) 0.87) than synthetic anti-inflammatory drugs (0.02-0.44). No significant difference of in vivo 5-lipoxidase activity (IC50 0.95mg/mL) than ibuprofen (IC50 0.93mg/mL) indicated the potential anti-inflammatory properties of the title compound.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available